Quality control report on the Panvascular Disease Management Center database(2024)
10.3969/j.issn.1004-8812.2025.07.002
- VernacularTitle:泛血管疾病管理中心数据库质控报告(2024)
- Author:
China Heart HOUSE
1
;
Jun-bo GE
1
Author Information
1. 复旦大学附属中山医院
- Collective Name:National Clinical Research Center for Interventional Medicine
- Publication Type:Journal Article
- Keywords:
Panvascular diseases;
Panvascular Disease Management Center;
Data quality control report
- From:
Chinese Journal of Interventional Cardiology
2025;33(7):368-375
- CountryChina
- Language:Chinese
-
Abstract:
To improve the diagnosis,treatment,and management of panvascular diseases,under the guidance of the National Clinical Research Center for Interventional Medicine,the Panvascular Medicine Expert Committee established a standardized registry database for panvascular diseases and encouraged all Panvascular Disease Management Centers(PVMCs)to submit case data.By the end of 2024,a total of 143 640 case records had been submitted by PVMCs.This report systematically evaluates the data quality of the database.The results show that the overall average completeness rate of mandatory fields was 79.23％.Among the patients,56.13％were male,with an average age of 60.71 years.The major cardiovascular risk factors included hypertension(36.96％),dyslipidemia(28.86％),diabetes(17.67％)and smoking(17.40％).Regarding medication use,statins had the highest utilization rate(95.86％).When analyzed by drug category-antiplatelet,anticoagulant,glucose-lowering,and antihypertensive medications-aspirin(85.71％),rivaroxaban(72.91％),sodium-glucose co-transporter 2 inhibitors(45.58％),and beta-blockers(50.01％)were the most frequently used in their respective groups.In the atherosclerotic cardiovascular disease(ASCVD)risk assessment,the proportions of high-risk,very high-risk,and extremely high-risk patients were 11.98％,14.57％,and 10.45％,respectively.At the 12-month follow-up after registration,the average total cholesterol level showed a significant decrease[(3.51±0.88)mmol/L vs.(4.82±1.21)mmol/L],while the average systolic blood pressure exhibited an increasing trend[(140.7±24.2)mmHg vs.(135.2±17.12)mmHg].As the first standardized,cross-disciplinary,multi-center collaborative database in China,it integrates multidimensional data,including risk factors,vascular lesion characteristics,and disease diagnosis and treatment measures.It covers the full spectrum of patients,from early high-risk populations to advanced ASCVD cases,with an emphasis on collecting imaging and biomarker data and tracking long-term clinical outcomes.We believe this database will provide high-quality data for precise risk stratification,optimized treatment,and real-world research in panvascular diseases.Through continuous upgrades of the information system and improvements in the quality control framework,the accuracy,completeness,and usability of the database have been further enhanced,contributing to the achievement of the"Healthy China"initiative's goal of reducing cardiovascular events.
